Q2 EPS Estimates for AnaptysBio Lifted by Leerink Partnrs
AnaptysBio, Inc. (NASDAQ:ANAB – Free Report) – Stock analysts at Leerink Partnrs increased their Q2 2025 earnings per share (EPS) estimates for shares of AnaptysBio in a report issued on Tuesday, May 6th. Leerink Partnrs analyst D. Risinger now forecasts that the biotechnology company will post earnings per share of ($0.89) for the quarter, up […]
AnaptysBio, Inc. (NASDAQ:ANAB – Free Report) – Stock analysts at Leerink Partnrs increased their Q2 2025 earnings per share (EPS) estimates for shares of AnaptysBio in a report issued on Tuesday, May 6th. Leerink Partnrs analyst D. Risinger now forecasts that the biotechnology company will post earnings per share of ($0.89) for the quarter, up […]
